Abstract
A disturbance in the antioxidant defense system including α-tocopherol, ascorbic acid and reduced glutahtione metabolism due to free radical induced oxidative injury has been implicated in various neuro-psychiatric disorders. The roles of these antioxidants, changes in their blood levels and correlation with oxidative stress were studied in a common psychiatric illness Schizophrenia. Fifty-eight subjects of either sex ranging in age from 18–60 years divided into two age groups (≤40 and >40 years) diagnosed for schizophrenia, and forty age and sex-matched normal subjects as controls were included in the study. Blood samples were analyzed for malondialdehyde (MDA), α-tocopherol, total ascorbic acid (TAA), dehydro ascorbic acid (DHAA), reduced ascorbic acid (RAA), leucocyte ascorbic acid (LAA) and reduced glutathione (GSH). A decrease in the levels of α-tocopherol, total ascorbic acid and reduced glutathione was found in schizophrenics compared to normal controls. Further a significant rise in oxidative stress and decreased antioxidant status was observed in the chronic stage of schizophrenia as compared to those in acute condition. A significant rise in dehydroascorbic acid with concomitant fall in reduced ascorbic acid suggests scavenging action of ascorbic acid and its utilization with increased oxidative stress as indicated by high blood malondialdehyde levels. Leucocyte ascorbic acid, a better index of ascorbic acid status was also found to be reduced in schizophrenics, suggesting depletion of body stores of ascorbic acid and the condition worsened with advancing age.
Key Words: Oxidative stress, Malondialdehyde, α-tocopherol, Ascorbic acid, Dehydroascorbic acid, Glutathione, Schizophrenia
Full Text
The Full Text of this article is available as a PDF (74.7 KB).
References
- 1.Sies H. Oxidative stress: From Basic Research to Clinical Application. Am. J. of Med. 1991;91:31S–38S. doi: 10.1016/0002-9343(91)90281-2. [DOI] [PubMed] [Google Scholar]
- 2.Lohr J. B. Oxygen Radicals and Neuropsychiatric Illnesses. Arch. Gen. Psychiatry. 1991;48:1097–1106. doi: 10.1001/archpsyc.1991.01810360061009. [DOI] [PubMed] [Google Scholar]
- 3.Mahadik S. P., Scheffer R. E. Oxidative Injury and Potential use of Antioxidants in Schizophrenia. Prostaglandins Leukot. Essent. Fatty Acids. 1996;55:45–54. doi: 10.1016/S0952-3278(96)90144-1. [DOI] [PubMed] [Google Scholar]
- 4.Dusica P., Vesna T. Oxidative stress as a marker of positive symptoms in Schizophrenia. Facta Universitatis. Medicine and Biology. 2002;9:157–161. [Google Scholar]
- 5.Sudha K., Rao A. V., Rao A. Oxidative stress and antioxidants in epilepsy. Clin. Chem. Acta. 2001;303:19–24. doi: 10.1016/S0009-8981(00)00337-5. [DOI] [PubMed] [Google Scholar]
- 6.Marshall W. J., Bangert S. K. Clinical Biochemistry; Metabolic and Clinical Aspects. London: Churchill living stone; 1995. Free radicals; pp. 765–777. [Google Scholar]
- 7.Chen L. H. Interaction of vitamin E and ascorbic acid (review) In Vivo. 1989;3:199–209. [PubMed] [Google Scholar]
- 8.Bandopadhyay D., Das D., Banerjee R. K. Reactive oxygen species: Oxidative damage and pathogenesis. Current Science. 1999;77:658–666. [Google Scholar]
- 9.Morrison A. P., French P., Walford L., Lewis J. W., Kilcommons A., Green A. J., Parker S., Bentall R. P. Cognitive therapy for the prevention of psychosis on people at ultra-high risk. Br. J. Psychiatry. 1991;185:291–7. doi: 10.1192/bjp.185.4.291. [DOI] [PubMed] [Google Scholar]
- 10.Kaplan H. I., Sadock B. J. Comprehensive Textbook of Psychiatry-V. Vol. 1. USA: Williams and Wilkins; 1989. Schizophrenia; pp. 699–815. [Google Scholar]
- 11.Natelson S. Techniques of Clinical Chemistry. 3rd Edition. Springfield, USA: Charles C Thomas; 1971. Determination of ascorbic acid by 2, 4-dinitrophenyl hydrazine; pp. 165–166. [Google Scholar]
- 12.Fabianek J., Filippi, Rickards T., Herp A. Micromethod for tocopherol determination in blood serum. Clin. Chem. 1968;14:456–462. [PubMed] [Google Scholar]
- 13.Denson K. W., Bowers E. F. The determination of ascorbic acid in white blood cells. Clin. Sci. 1961;21:157–162. [PubMed] [Google Scholar]
- 14.Beutler E. A Manual of Biochemical Methods. New York: Grune and Stration; 1971. Red cell metabolism; pp. 103–105. [Google Scholar]
- 15.Stock J., Dormandy T. L. The Autoxidation of Human Red Cell Lipids induced by hydrogen peroxide. Br. J. of Haematol. 1971;20:95–111. doi: 10.1111/j.1365-2141.1971.tb00790.x. [DOI] [PubMed] [Google Scholar]
- 16.Halliwell B. Free radicals, antioxidants and human diseases: Curiosity, cause or consequence? Lancet. 1994;344:721–724. doi: 10.1016/S0140-6736(94)92211-X. [DOI] [PubMed] [Google Scholar]
- 17.Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am. J. of Med. 1994;97:5S–13S. doi: 10.1016/0002-9343(94)90292-5. [DOI] [PubMed] [Google Scholar]
- 18.Benedicta D., Vivian D. Oxidative injury and antioxidant vitamins E and C in Schizophrenia. Ind. J. of Clin. Biochem. 2003;18:87–90. doi: 10.1007/BF02867671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ansari K. U. Free Radical induced diseases. JIMA. 1996;94(1–12):238–9. [PubMed] [Google Scholar]
- 20.Niki E. Antioxidants in relation to lipid peroxidation. Chem. of Physiol. Lipids. 1987;44:227–253. doi: 10.1016/0009-3084(87)90052-1. [DOI] [PubMed] [Google Scholar]
- 21.Niki E. Interaction of ascorbate and alphatocopherol. Ann. N. Y. acad. Sci. 1987;498:186–199. doi: 10.1111/j.1749-6632.1987.tb23761.x. [DOI] [PubMed] [Google Scholar]
- 22.Mann G. V., Newton P. The membrane transport of ascorbic acid. Ann. N. Y. acad. Sci. 1975;258:243–252. doi: 10.1111/j.1749-6632.1975.tb29285.x. [DOI] [PubMed] [Google Scholar]
- 23.Loh H. S., Wilson C. W. M. Relationship between leucocyte and plasma ascorbic acid concentrations. BMJ. 1971;3:733–735. doi: 10.1136/bmj.3.5777.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kojo S. Vitamin C: basic metabolism and its function as an index of oxidative stress. Curr. Med. Chem. 2004;11(8):1041–64. doi: 10.2174/0929867043455567. [DOI] [PubMed] [Google Scholar]